BIOMAT Database Logo BIOMAT Database Logo

[On the treatment of severe burns by Trasylol, an enzyme inactivator]. 1962

L KOWLOWSKI, and D BARCKOW, and G WASCHKEIT

UI MeSH Term Description Entries
D007611 Aprotinin A single-chain polypeptide derived from bovine tissues consisting of 58 amino-acid residues. It is an inhibitor of proteolytic enzymes including CHYMOTRYPSIN; KALLIKREIN; PLASMIN; and TRYPSIN. It is used in the treatment of HEMORRHAGE associated with raised plasma concentrations of plasmin. It is also used to reduce blood loss and transfusion requirements in patients at high risk of major blood loss during and following open heart surgery with EXTRACORPOREAL CIRCULATION. (Reynolds JEF(Ed): Martindale: The Extra Pharmacopoeia (electronic version). Micromedex, Inc, Englewood, CO, 1995) BPTI, Basic Pancreatic Trypsin Inhibitor,Basic Pancreatic Trypsin Inhibitor,Bovine Kunitz Pancreatic Trypsin Inhibitor,Kallikrein-Trypsin Inactivator,Kunitz Pancreatic Trypsin Inhibitor,Trypsin Inhibitor, Basic, Pancreatic,Trypsin Inhibitor, Kunitz, Pancreatic,Antilysin,Bovine Pancreatic Trypsin Inhibitor,Contrical,Contrykal,Dilmintal,Iniprol,Kontrikal,Kontrykal,Pulmin,Traskolan,Trasylol,Zymofren,Inactivator, Kallikrein-Trypsin,Kallikrein Trypsin Inactivator
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D002056 Burns Injuries to tissues caused by contact with heat, steam, chemicals (BURNS, CHEMICAL), electricity (BURNS, ELECTRIC), or the like. Burn
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

L KOWLOWSKI, and D BARCKOW, and G WASCHKEIT
[Postoperative parotitis. New methods of treatment with the enzyme inactivator trasylol].
May 1963, Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen,
L KOWLOWSKI, and D BARCKOW, and G WASCHKEIT
[On the treatment of hemophilia B with kallikrein inactivator (trasylol)].
January 1967, Verhandlungen der Deutschen Gesellschaft fur Innere Medizin,
L KOWLOWSKI, and D BARCKOW, and G WASCHKEIT
The influence of the kallikreintrypsin inactivator "Trasylol" on the serum cholinesterase.
January 1969, British journal of anaesthesia,
L KOWLOWSKI, and D BARCKOW, and G WASCHKEIT
[Experimental data on the efficacy of the kallikrein-trypsin inactivator (Trasylol)].
June 1961, Klinische Wochenschrift,
L KOWLOWSKI, and D BARCKOW, and G WASCHKEIT
[Treatment of burns with a ferment inactivator].
December 1960, Klinische Wochenschrift,
L KOWLOWSKI, and D BARCKOW, and G WASCHKEIT
[The kallikrein inactivator and trypsin ("Trasylol") in the treatment of acute pancreati steatonecrosis].
May 1962, Medicina espanola,
L KOWLOWSKI, and D BARCKOW, and G WASCHKEIT
The influence of the kallikrein-trypsin inactivator Trasylol on the serum cholinesterase.
June 1968, British journal of anaesthesia,
L KOWLOWSKI, and D BARCKOW, and G WASCHKEIT
[TREATMENT OF ACUTE PANCREATIC DISEASES WITH AN ENZYME INACTIVATOR].
September 1963, La Clinica terapeutica,
L KOWLOWSKI, and D BARCKOW, and G WASCHKEIT
[ROLE OF TRASYLOL--TRYPSIN INACTIVATOR--AND KALLIKREIN IN PANCREATITIS].
June 1964, Polski tygodnik lekarski (Warsaw, Poland : 1960),
L KOWLOWSKI, and D BARCKOW, and G WASCHKEIT
[Preliminary experiences with the kallikrein inactivator "trasylol" in acute pancreatitis].
March 1961, Klinische Medizin; osterreichische Zeitschrift fur wissenschaftliche und praktische Medizin,
Copied contents to your clipboard!